secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2024-11-15T23:59:59+00:00
Accession:  0001654954-24-014503
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zivo restructures $277k debt into unsecured notes payable over 24 months at 1%
------------------------------------------------------------------------------

- Debt Settlement Agreements with three creditors executed on Nov 12, 2024.
- Total principal $277,254 via notes to Howard Shapiro ($185.5k), Merger Masters ($40.3k), Financial Trading ($51.4k).
- Notes bear 1% annual interest, payable in 24 equal monthly installments starting Nov 30, 2024.
- Prepayment permitted without penalty; customary events of default apply.
- Restructuring converts existing obligations into unsecured promissory notes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495424014503/0001654954-24-014503-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495424014503/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-014503

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer